PresentationMohit BansalSenior Equity Analyst All right. Thank you very much for joining us today. My name is Mohit Bansal. I am one of the biotech pharma analysts here at Wells Fargo. And this is my first session of the morning. And I'm very happy to have, from BioMarin, Greg Friberg with us. Greg is the EVP and Chief Research and Development Officer at BioMarin. Thank you very much for being here. ...